Biohit signs licencing agreement with Randox
Biohit Oyj Press Release November 27, 2013 at 5 P.M. local time (EET) Finnish healthcare company Biohit Oyj and Randox Laboratories have signed a licensing agreement which gives Randox the worldwide licensing rights for GastroPanel developed by Biohit. GastroPanel developed by Biohit is a simple, non-invasive blood test for the diagnosis and screening of gastric disorders. GastroPanel test reliably detects H. pylori infection and damage or dysfunction of the stomach mucosa (atrophic gastritis), leading to acid-free stomach. According to latest studies, non-acid stomach is a remarkable